For the Inventor, By the Inventor

Enter inventor name

Seoul, South Korea

Sujeong Kim

USPTO Granted Patents = 14 (Patent Applications = 8)

CIPO Patents = 9 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 10)

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Hwaseong-si, KR (2023)
Seoul, KR (2009 - 2024)

Company Filing History:

Kolon Life Science, Inc.

5 out of 131,214

Samsung Electronics Co., Ltd.

Viromed Co., Ltd.

Kolon Tissuegene, Inc.

where one patent can have more than one assignee

Years Active: 2009-2025

where 'Filed Patents' based on already Granted Patents

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12189560 - Apparatus and method for training device-to-device physical interface (2025-01-07),

2. 12119049 - Memory controller performing data training, system-on-chip including the memory controller, and operating method of the memory controller (2024-10-15),

3. 12062606 - Memory device (2024-08-13),

4. 11862624 - Integrated circuit device with protective antenna diodes integrated therein (2024-01-02),

5. 11830541 - Memory controller performing data training, system-on-chip including the memory controller, and operating method of the memory controller (2023-11-28),

6. 11452770 - Recombinant vaccinia virus and use thereof (2022-09-27),

7. 11433145 - Composition for treating pain (2022-09-06),

8. 11191787 - Composition for treating inflammatory disease induced by hyperimmune response (2021-12-07),

9. 11001860 - Poxvirus-derived promoter, and vector comprising same (2021-05-11),

10. 10898590 - Method for delivery of biological molecule to nervous tissue (2021-01-26),

11. 8389492 - Lyophilized DNA formulations for enhanced expression of plasmid DNA (2013-03-05),

12. 8106158 - Compositions and methods for fusion protein separation (2012-01-31),

13. 8105575 - Expression vectors with improved safety (2012-01-31),

14. 7585943 - Compositions and methods for fusion protein separation (2009-09-08),

Title: Sujeong Kim: Innovator in Cancer Treatment

Introduction

Sujeong Kim is a notable inventor from South Korea, recognized for his contributions to the field of cancer treatment through innovative technologies. His work primarily focuses on recombinant vaccinia viruses, which have shown promising results in targeting cancer cells while minimizing harm to normal cells.

Latest Patents

Sujeong Kim has developed several significant patents, including:

1. **Recombinant Vaccinia Virus And Pharmaceutical Composition Comprising Same** - This invention relates to a recombinant vaccinia virus that includes a gene encoding sPD-1 or hyaluronidase. The virus is designed to suppress the expression of certain genes, resulting in an effective anti-tumor effect, making it a valuable tool in cancer therapy.

2. **Recombinant Vaccinia Virus And Use Thereof** - This patent describes a recombinant vaccinia virus that selectively targets and kills cancer cells. It boasts excellent reproducibility in cancer cells and lower toxicity to normal cells, highlighting its potential as a safe and effective treatment option for cancer patients.

Career Highlights

Throughout his career, Sujeong Kim has worked with prominent companies in the biotechnology sector. He has been associated with Kolon Life Science, Inc. and Viromed Co., Ltd., where he has contributed to the advancement of medical technologies aimed at improving patient outcomes.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Sujeong Kim's innovative work in developing recombinant vaccinia viruses represents a significant advancement in cancer treatment. His contributions have the potential to improve the safety and efficacy of cancer therapies, making a lasting impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…